TY - JOUR
T1 - In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa
AU - Greenberg, R. N.
AU - Bollinger, M. R.
AU - Alivisatos, M. R.
PY - 1986
Y1 - 1986
N2 - The in vitro susceptibility of 103 well-characterized strains of Pseudomonas aeruginosa to nine antimicrobial agents was assessed by means of the Kirby-Bauer disk diffusion assay and the microtiter minimal inhibitory concentration assay. The antimicrobials, from the most to the least active against P aeruginosa, were thienamycin > ceftazidime > piperacillin > azlocillin > cefoperazone > aztreonam > ticarcillin > ticarcillin-clavulanic acid > mezlocillin. The resistance patterns of the antimicrobial agents suggest that P aeruginosa resistant to a penicillin, cephalosporin, or aztreonam may be susceptible to thienamycin.
AB - The in vitro susceptibility of 103 well-characterized strains of Pseudomonas aeruginosa to nine antimicrobial agents was assessed by means of the Kirby-Bauer disk diffusion assay and the microtiter minimal inhibitory concentration assay. The antimicrobials, from the most to the least active against P aeruginosa, were thienamycin > ceftazidime > piperacillin > azlocillin > cefoperazone > aztreonam > ticarcillin > ticarcillin-clavulanic acid > mezlocillin. The resistance patterns of the antimicrobial agents suggest that P aeruginosa resistant to a penicillin, cephalosporin, or aztreonam may be susceptible to thienamycin.
UR - http://www.scopus.com/inward/record.url?scp=0022979219&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022979219&partnerID=8YFLogxK
M3 - Article
C2 - 3098426
AN - SCOPUS:0022979219
SN - 0149-2918
VL - 8
SP - 655
EP - 657
JO - Clinical Therapeutics
JF - Clinical Therapeutics
IS - 6
ER -